The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancer

Leila Hosseinzadeh,Zoya Kikhtyak,Geraldine Laven-Law,Stephen M. Pederson,Caroline G. Puiu,Clive S. D’Santos,Elgene Lim,Jason S. Carroll,Wayne D. Tilley,Amy R. Dwyer,Theresa E. Hickey
DOI: https://doi.org/10.1186/s13059-023-03161-y
IF: 17.906
2024-02-07
Genome Biology
Abstract:The androgen receptor (AR) is a tumor suppressor in estrogen receptor (ER) positive breast cancer, a role sustained in some ER negative breast cancers. Key factors dictating AR genomic activity in a breast context are largely unknown. Herein, we employ an unbiased chromatin immunoprecipitation-based proteomic technique to identify endogenous AR interacting co-regulatory proteins in ER positive and negative models of breast cancer to gain new insight into mechanisms of AR signaling in this disease.
genetics & heredity,biotechnology & applied microbiology
What problem does this paper attempt to address?